Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 32, Issue 12, 2005, Pages 2291-2298

  Schlenk, Judith ^a   Lorenz, Hanns Martin ^b   Haas, Johannes Peter ^c   Herrmann, Martin ^a   Hohenberger, Gerd ^d   Kalden, Joachim R ^a   Röllinghoff, Martin ^a   Beuscher, Horst Ulrich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d Orthopedic Clinic Rummelsberg   (Germany)

Author keywords

Ccl20 macrophage inflammatory protein 3 ; Chemokines; Polymorphonuclear neutrophils; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ADALIMUMAB; ARTHROTEC; AZATHIOPRINE; CELECOXIB; CHLOROQUINE; COMPLEMENTARY DNA; CORTISONE; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IBUPROFEN; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; METHOTREXATE; MISOPROSTOL; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; ROFECOXIB; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; INFLAMMATION; MALE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGED; NEUTROPHILS; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28844487770     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
2. Symmons DP. Environmental factors and the outcome of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:717-27.
3. Weyand CM, Goronzy JJ. Inherited and noninherited risk factors in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:206-13.
4. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
5. Lorenz HM, Kalden JR. Perspectives for TNF-alpha-targeting therapies. Arthritis Res 2002;4 Suppl 3:17-24.
6. Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 1999;66:286-92.
7. Kraan MC, Patel DD, Haringman JJ, et al. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res 2001;3:65-71.
8. Buckley CD. Why do leucocytes accumulate within chronically inflamed joints? Rheumatology Oxford 2003;42:1433-44.
9. Koch AE, Kunkel SL, Burrows JC, et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
10. Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Stricter RM. Growth-related gene product alpha. A chemotactic cytokine tor neutrophils in rheumatoid arthritis. J Immunol 1995;155:3660-6.
11. Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992;149:722-7.
12. Gasperini S, Calzetti F, Russo MP, De Gironcoli M, Cassatella MA. Regulation of GRO alpha production in human granulocytes. J Inflamm 1995;45:143-51.
13. Yamashiro S, Kamohara H, Yoshimura T MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression. J Leukoc Biol 1999;65:671-9.
14. Kasama T, Strieter RM, Standiford TJ, Burdick MD, Kunkel SL. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med 1993;178:63-72.
15. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991;173:771-4.
16. Scapini P, Laudanna C, Pinardi C, et al. Neutrophils produce biologically active macrophage inflammatory protein-3 alpha (MIP-3 alpha)/CCL20 and MIP-3 beta/CCL19. Eur J Immunol 2001;31:1981-8.
17. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991;10:245-52.
18. Koch AE, Kunkel SL, Shah MR, et al. Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995;155:3660-6.
19. Koch AE, Kunkel SL, Harlow LA, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
20. Matsui T, Akahoshi T, Namai R, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol 2001;125:155-61.
21. Beaulieu AD, McColl SR. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 1994;37:855-9.
22. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3 alpha and is highly expressed in human dendritic cells. J Exp Med 1997;186:837-44.
23. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999;162:186-94.
24. Krzysiek R, Lefevre EA, Bernard J, et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3 alpha/CCL20 in human B cells. Blood 2000;96:2338-45.
25. Scapini P, Crepaldi L, Pinardi C, Calzetti F, Cassatella MA. CCL20/macrophage inflammatory protein-3 alpha production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucyl- phenylalanine and IFN-gamma through independent mechanisms. Eur J Immunol 2002;32:3515-24.
26. Ruth JH, Shahrara S, Park CC, et al. Role of macrophage inflammatory protein-3 alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest 2003;83:579-88.
27. Giudicelli J, Philip PJ, Delque P, Sudaka P. A single-step centrifugation method for separation of granulocytes and mononuclear cells from blood using discontinuous density gradient of Percoll. J Immunol Methods 1982;54:43-6.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
29. Nakayama T, Fujisawa R, Yamada H, et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001;13:95-103.
30. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, et al. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003;41:354-70.
31. Harris SG, Smith RS, Phipps RP. 15-deoxy-delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. Immunol 2002;168:1372-9.
32. Eggleton P, Wang L, Penhallow J, Crawford N, Brown KA. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:916-23.
33. Sukedai M, Tominaga K, Habu M, Matsukawa A, Nishihara T, Fukuda J. Involvement of tumor necrosis factor-alpha and interleukin-8 in antigen-induced arthritis of the rabbit temporomandibular joint. J Oral Pathol Med 2004;33:102-10.
34. Shealy DJ, Wooley PH, Emmell E, et al. Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice. Arthritis Res 2002;4:R7. Epub 2002 June 28.
35. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96.
36. Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, Maini RN. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38-47.
37. Barrera P, Joosten LA, den Breeder AA, van de Putte LB, van Riel PL, van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNF alpha in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:660-9.
38. Cuchacovich M, Ferreira L, Aliste M, Aguirre A. Salazar-Onfray F, Aguillon JC. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand J Rheumatol 2004;33:228-32.
39. Cross A, Bucknall RC, Cassatella MA, Edwards SW, Moots RJ. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum 2003;48:2796-806.
40. Hanyuda M, Kasama T, Isozaki T Matsunawa MM, Yajima N, Adachi M. Activated leucocytes express and secrete macrophage inflammatory protein-1 alpha upon interaction with synovial fibroblasts of rheumatoid arthritis via a beta 2-integrin/ICAM-1 mechanism. Rheumatology Oxford 2003;42:1390-7.